ASP Isotopes (NASDAQ:ASPI) Issues Earnings Results

ASP Isotopes (NASDAQ:ASPI) released its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11), Zacks reports. The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

ASP Isotopes Price Performance

NASDAQ:ASPI opened at $4.20 on Tuesday. The business’s 50-day moving average price is $4.33 and its 200 day moving average price is $5.19. The firm has a market cap of $643.90 million, a P/E ratio of -3.18 and a beta of 3.59. ASP Isotopes has a 52-week low of $3.51 and a 52-week high of $14.49. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76.

Analysts Set New Price Targets

ASPI has been the subject of several research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $13.00.

Insider Activity at ASP Isotopes

In other news, CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total transaction of $145,218.72. Following the completion of the sale, the chief financial officer owned 1,526,252 shares in the company, valued at approximately $9,584,862.56. This represents a 1.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Todd Wider sold 50,000 shares of ASP Isotopes stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $6.25, for a total value of $312,500.00. Following the completion of the transaction, the director directly owned 722,247 shares in the company, valued at approximately $4,514,043.75. This represents a 6.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 295,641 shares of company stock worth $1,414,224. Company insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors and hedge funds have recently bought and sold shares of the business. Quantbot Technologies LP bought a new stake in ASP Isotopes in the third quarter valued at $34,000. BNP Paribas Financial Markets increased its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares in the last quarter. Guggenheim Capital LLC acquired a new stake in ASP Isotopes in the 4th quarter valued at about $72,000. Caption Management LLC lifted its position in shares of ASP Isotopes by 110.5% during the fourth quarter. Caption Management LLC now owns 13,800 shares of the company’s stock worth $74,000 after purchasing an additional 145,800 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC acquired a new position in ASP Isotopes during the 4th quarter worth $74,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.